Citations

Mayo Clinic

Clear

4526 citation(s) found for "Muñoz, Maria".

Beyond the Dermatome: Varicella-Zoster Virus Hits the Brain and Heart
Monsanto, Michael Acevedo , Decosma, Lorvens , Lopez, Camily Morales, Coutinho, Maria Vitoria , Chirilă, Răzvan M.

Annals of Internal Medicine: Clinical Cases | July 7, 2026 | Volume: 5 | Issue: 7 | Pages: No page available

10.7326/aimcc.2026.0038 Get It

Association of white matter hyperintensities, white matter microstructural changes, hippocampal and amygdala volumes with neuropathology in a community cohort using 7T postmortem in situ MRI
Liou, Jr‐Jiun , Martin, Maria, Rodriguez, Roberta, Grinberg, Lea, Santini, Tales, Ibrahim, Tamer , Otaduy, Maria, Rodriguez, Roberta Diehl , Santini, Tales , Otaduy, Maria Concepción García

No container title available | July 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.30.26356455 | PMID 42465946 Get It

Abstract INTRODUCTION We integrate visual and quantitative metrics in white matter and medial temporal lobe to examine relationships with neuropathology in a community cohort. METHODS Postmortem in situ MRI (T1, T2, DWI) was performed in 25 human brains, followed by visual ratings (Fazekas, MTA, ERICA, Koedam). Neuropathology included ADNC, LATE-NC, hippocampal sclerosis, PART, ARTAG, Lewy pathology, and CAA. RESULTS Increased Fazekas score was linked to aging, lower education, hypertension, higher basilar artery wall thickness, and greater Braak NFT stage. WMH volume also correlated with lacunes, Thal phase, and CERAD score that was not observed using Fazekas. Hippocampal volumes were lower in elderly, less educated people and were associated with higher atrophy scores and higher Braak NFT stage. Higher amygdala volume was only associated with higher CERAD score. DISCUSSION Quantitative MRI may detect neuropathologic associations more sensitively than visual ratings. Tau pathology is a key predictor of WMH burden and hippocampal atrophy.
Building community trust through medical education: a four-year descriptive analysis of a national grant program
Hedges, Mary S., Dent, Randl, Lynch, Timothy, Miguel, Maria de, Hedges, Mary S.

Frontiers in Public Health | July 6, 2026 | Volume: 14 | Issue: No issue available | Pages: No page available

10.3389/fpubh.2026.1862984 | PMID 42518559 Get It

Community engagement and trust are vital to medical education and improving health. The experience of national level, extramural seed grant programs to support faculty in both education and health care delivery with the focus of building trust has not been previously reported. The authors reviewed a total of four cohorts of the “Building Trust: Advancing Health Equity” grant recipients supported by the ABIM Foundation and other funding partners. Over $1.5 million was awarded from 2021 to 2024, which represented 92 grants ranging from $2,500–$40,000 each. The geographic regions receiving the most grants and funding were the middle and south Atlantic, and the Pacific regions in the United States. University programs received more grants and funding than affiliated or community programs. The majority of project types primarily focused on developing educational curricula for internal medicine residents (68%) and engaging with local communities (19%). The approach to implementation often included service-learning and community experts (29%), quality improvement and patient care delivery methods (22%), and traditional curriculum development (21%). The most common education topic themes were health equity and social determinants of health (43%) and addressing bias in care delivery and learning environment (20%). The Building Trust grant program reflects the unique needs of local communities and supported innovative practices and educational techniques. Implementation support was provided to grantees through shared experiences and mentorship. Evaluating outcomes upon completion of grants will be an imperative next step. This serves as a model that can inform institutions and other professional organizations approaching implementation of seed grant funding.
Renovascular disease induces functionally relevant, locus-specific alterations to DNA methylation and hydroxymethylation in swine scattered tubular-like cells
Iyer, Vinaya C., Shivam, Kumar, Kazeminia, Sara , Zhu, Xiang-Yang, Tang, Hui, Xue, Ailing, Chade, Alejandro , Lerman, Lilach O. , Herrmann, Sandra, Irazabal, Maria V , Lerman, Lilach O , Eirin, Alfonso , Kazeminia, Sara , Herrmann, Sandra M. , Irazabal, María V. , Eirin, Alfonso

American Journal of Physiology-Renal Physiology | July 2, 2026 | Volume: 331 | Issue: 2 | Pages: F213-F224

10.1152/ajprenal.00055.2026 | PMID 42390182 Get It

Scattered tubular-like cells (STCs) are dedifferentiated renal tubular cells that repair other damaged kidney cells. This study shows that renovascular disease (RVD) induces site-specific 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) modifications in DNA associated with transcriptional changes and impaired proliferative capacity of swine STCs, which could be mitigated in RVD-STCs treated with an epigenetic modulator. Therefore, our observations may contribute to the development of novel approaches to preserve the reparative capacity of STCs in individuals with RVD.
Caregiver Reports of Lucid Episodes in Alzheimer’s Dementia and Lewy Body Dementias
Bangerter, Lauren R. , Kim, Kyungmin , Liu, Yin, Radford, Jonathan Graff, Liu, Yin, Lapid, Maria I. , Griffin, Joan M.

Journal of Geriatric Psychiatry and Neurology | July 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/08919887261464594 | PMID 42387273 Get It

Purpose of Research Lucidity is the transient recovery of abilities and communication that were seemingly lost among people living with dementia (PLWD). This study describes lucid episodes reported by Alzheimer’s dementia (AD) and Lewy Body Dementias (LBD) caregivers. We analyzed survey data from 212 current AD ( n = 191) and LBD caregivers who reported the frequency, duration, and characteristics of 653 lucid episodes witnessed in the past month. Major Findings Most AD caregivers (67%) and LBD caregivers (81%) witnessed a lucid episode within the past month. LBD caregivers reported lucid episodes with greater changes in awareness and communication, compared to AD caregivers. LBD caregivers reported longer lucid episodes and that the PLWD knew about their change in lucidity, compared to AD caregivers. Conclusions Findings suggest that differences in lucid episode intensity, timing, and meta-awareness between AD and LBD are possible and may inform care strategies for PLWD.
100 Translating EVD management guidelines into clinical practice: a modified delphi approach to an educational infographic development
Han, Enya S, Senat, Junior, Pelt, Maria van, White-Dzuro, Gabrielle, Abcejo, Arnoley S, Lele, Abhijit V, White-Dzuro, Gabrielle A. , Lele, Abhijit Vijay

100 Translating EVD management guidelines into clinical practice: a modified delphi approach to an educational infographic devel | July 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: A99.2-A100

10.1136/bmjoq-2026-qsho.100 Get It

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE
Crew, Katherine D. , Arnold, Kathryn B. , Dzingle, Sam, Michel, Alissa, DeLucie, Michael, Law, Cynthia W., Pruthi, Sandhya , Leon, Ana C Sandoval, Shirley, Rachel, Perdekamp, Maria T Grosse, Colonna, Sarah V, Krisher, Stacy L, King, Tari A. , Yee, Lisa D. , Braun-Inglis, Christa, Mangino, Debra A. , Wisinski, Kari B. , DeYoung, Claudia A, Ross, Masey, Floyd, Justin D., Kaster, Andrea, VanderWalde, Lindi, Saphner, Thomas J. , Zarwan, Corrine, Lo, Shelly, Graham, Cathy, Conlin, Alison, Yost, K. , Agnese, Doreen M, Jernigan, Cheryl, Neuhouser, Marian L, Arun, Banu, Pruthi, Sandhya , Anderson, Garnet L. , Michel, Alissa , DeLucie, M. T., Sandoval-Leon, Ana Cristina , Shirley, Rachel, Perdekamp, Maria T. Grosse, Colonna, Sarah V. , Krisher, Stacy, Ballinger, Tarah Jean , Braun‐Inglis, Christa , Ross, Masey, Graham, Cathy Lynne , Yost, Kathleen J. , Agnese, Doreen Marie , Hershman, Dawn L. , Zell, Jason A. , Kukafka, Rita

JNCI: Journal of the National Cancer Institute | June 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jnci/djag216 | PMID 42391096 Get It

Abstract Background Breast cancer chemoprevention is underutilized among high-risk women. We examined whether decision support could increase informed decision making. Methods We conducted a cluster randomized controlled trial to evaluate the effect of a patient-facing decision aid (RealRisks) and provider tool (BNAV) compared with standard education on the number of women with high-risk breast lesions making informed choices. Questionnaires were administered at baseline and 6 and 12 months. The primary outcome was chemoprevention informed choice (defined as adequate knowledge and attitudes congruent with decision) at 6 months. Secondary endpoints included breast cancer risk perceptions, worry, chemoprevention knowledge, decision conflict, and chemoprevention decision. Results Across 31 randomized sites, we enrolled 210 providers, who were primarily breast health specialists. Of these, 24 sites (14 intervention, 10 control) enrolled 412 patients. Among 287 patients evaluable for the primary outcome, there were no statistically significant differences in informed choice between the intervention and control arms at 6 months (35% vs 27%, respectively; P = .20) and 12 months (37% vs 25%, respectively; P = .05). At 6 months, women in the intervention compared with control arm were more likely to have accurate breast cancer risk perceptions (31% vs 21%, respectively; P = .03) and adequate chemoprevention knowledge (33% vs 23%, respectively; P = .04). At 12 months, 52% of women in the control and 50% in the intervention arm self-reported initiating chemoprevention. Conclusion Decision support led to modest improvements in accurate risk perceptions and chemoprevention knowledge but not informed choice. Relatively high chemoprevention uptake was achieved among women with high-risk breast lesions managed mainly by breast health specialists. Trial Registration NCT04496739, https://clinicaltrials.gov/study/NCT04496739?cond=NCT04496739&viewType=Card&rank=1
NMDAR ‐antibody encephalitis: Seizure semiology and EEG findings
Andraus, Maria Emília Cosenza , Liem, Bernard , Aurangzeb, Sidra , Symmonds, Mkael , Handel, Adam E. , Irani, Sarosh R. , Andraus, Maria Emilia C , Sen, Arjune , Irani, Sarosh R , Handel, Adam

Epileptic Disorders | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/epd2.70327 | PMID 42363715 Get It

Abstract Background N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a first episode of NMDAR‐Ab‐E. Methods Medical records and EEG results were retrospectively evaluated from 14 adult patients with definite NMDAR‐Ab‐E, recruited between April 2009 and September 2017, and followed up until October 2024. Results A total of 92.8% (13/14) were women with a mean age of 29.6 years. 85.7% (12/14) patients experienced seizures. Focal and/or generalized seizures were described at presentation or in the first days of the illness in 57% (8/14). EEGs showed diffuse slowing in 13/14 and this coexisted with epileptiform activity in 10/13; fast frequencies in 7/13 (potentially owing to a benzodiazepine effect); and asymmetric focal slowing in 6/13. Six patients had periods of rhythmic slow activity (focal or diffuse), without evolution to electrographic seizures. An extreme delta brush (EDB) pattern was recorded in 2/13 patients, and this was associated with non‐convulsive status epilepticus in one of these individuals. Significance Most patients in this case series of NMDAR‐Ab‐E were young adult females with early focal and/or generalized seizures. Diffuse slowing in theta/delta range was the most common EEG finding, with or without epileptiform discharges, focal slowing, superimposed fast activities, and focal or diffuse rhythmic slowing. An EDB pattern was rare. Even with non‐specific findings, EEG seems to be a sensitive tool to aid diagnosis and decision‐making in NMDAR‐Ab‐E.
Prognostic impact of ventricular arrhythmia timing in acute coronary syndromes treated with percutaneous coronary intervention: a systematic review and meta-analysis
Pizzi, D, Fazzini, L, Pugliesi, G M, Faizan, M A, Rehman, T, Meshkati, H, Perego, G B, Curti, E, Senni, M, Gori, M, Jentzer, J J, Fazzini, Luca , Pugliesi, Giordano Maria , Rehman, Tooba , Perego, Giovanni Battista , Curti, Emanuele, Senni, Michele , Gori, Mauro

Europace | June 25, 2026 | Volume: 28 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euag105.1031 Get It

Abstract Background Ventricular arrhythmias (VA) are common complications of acute coronary syndromes (ACS) and can cause cardiac arrest and adverse outcomes. However, the prognostic impact of VA according to their timing in relation to percutaneous coronary intervention (PCI) remains unclear. Purpose To assess the prognostic significance of VA in patients with ACS undergoing PCI according to the timing of occurrence (before, during, or after PCI). Methods We performed a systematic review and meta-analysis of observational studies reporting all-cause mortality with and without VA (sustained VT/VF) in ACS patients undergoing PCI. Pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using random-effects models for short-term (30 days/in-hospital) and long-term (1 year) mortality. Between-study heterogeneity was assessed using the I² statistic. We conducted subgroup analyses for studies that stratified VA according to timing, defined as VA before PCI (prior to arrival in the catheterization laboratory), VA during PCI (in the catheterization laboratory or immediately after reperfusion), VA after PCI (following completion of PCI). Each timing category was compared to patients who did not develop VA within the same time window (before, during or after PCI). Results Twelve studies comprising 49306 patients were included, of whom 4320 (8.76%) experienced VA. The mean age of the patients ranged from 60 to 70 years, and the follow-up ranged from hospital discharge to 8 years. VA was associated with increased short-term (OR 5.02 [3.91-6.44]) and long-term mortality (OR 3.00 [2.86-3.82]). However, in patients alive at discharge/30 days, subsequent long-term mortality risk did not differ between those with and without VA (OR 1.21 [0.70-2.09]) (Figure 1). The subgroup analyses showed that patients with VA were associated with higher short-term mortality compared to patients without VA within each time window: before (OR 4.32 [3.29-5.66]), during (OR 4.29 [2.08-8.84]), and after PCI (OR 9.29 [3.12-27.63]) (Figure 2). VA after PCI was associated with the highest OR for short-term mortality. Conclusions VA significantly worsens short-term outcomes in ACS patients undergoing PCI. Subgroup analysis shows that VA increases mortality in each timing category, before, during and after PCI, with the poorest prognosis observed for arrhythmias developed after reperfusion, in whom reversible acute ischemia may play a lesser role and underlying arrhythmic substrate may predominate.Figure 1Figure 2
Late‐onset copper and zinc deficiency following Roux‐en‐Y gastric bypass (RYGB): A case report and review of the literature
Flores-Patiño, José J. , Maya‐Salazar, Claudia , Vera‐Ibarra, René Daniel , Hernández‐Ayala, Karina , Arízaga-Berber, José Adán , Gastélum-Cano, José María , Delgado-Zaldívar, Diego , López, Fernando Gil, Torruco-Sotelo, Carlos , Flores-Patiño, José Juan , Arízaga-Berber, José A , Gastélum-Cano, José M , Gil-López, Fernando, Ayala, Karina Hernandez , Gil-López, F. Santoyo

Nutrition in Clinical Practice | June 25, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ncp.70145 | PMID 42347905 Get It

Abstract Roux‐en‐Y gastric bypass (RYGB) surgery is a highly effective technique for treating obesity. However, it may result in nutritional deficiencies. Here we report the case of a 55‐year‐old woman presenting with chronic diarrhea lasting 2 years, accompanied by lower limb paresthesia, macrocytic anemia, leukopenia, and thrombocytopenia. Her medical history included hypothyroidism treated with levothyroxine, and RYGB surgery performed in 2014, with intermittent micronutrient supplementation. The patient developed copper and zinc deficiencies. To our knowledge, this is the first report of a patient presenting with both deficiencies simultaneously with pancytopenia 10 years after RYGB. This case underscores the need to verify adherence to existing preoperative screening recommendations involving preoperative micronutrient measurements to assess micronutrient deficiency risks and multidisciplinary postoperative follow‐up, the importance of monitoring micronutrient levels, close follow‐up of both symptomatic and asymptomatic patients and evaluating adherence to supplementation regimens.